BlackRock’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

BlackRock’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,068,828	Closed	-$53.4K	–	5515
2023 Q3	$53.4K	Hold	1,068,828	–	–	﹤0.01%	4990
2023 Q2	$225K	Sell	1,068,828 -509	-0%	-$128	﹤0.01%	4705
2023 Q1	$171K	Sell	1,069,337 -48,624	-4%	-$14.3K	﹤0.01%	4820
2022 Q4	$246K	Sell	1,117,961 -2,642	-0.2%	-$2.29K	﹤0.01%	4796
2022 Q3	$2.96M	Hold	1,120,603	–	–	﹤0.01%	3995
2022 Q2	$761K	Sell	1,120,603 -23,091	-2%	-$23.9K	﹤0.01%	4645
2022 Q1	$1.81M	Sell	1,143,694 -12,635	-1%	-$18.2K	﹤0.01%	4438
2021 Q4	$2.76M	Hold	1,156,329	–	–	﹤0.01%	4271
2021 Q3	$4.78M	Hold	1,156,329	–	–	﹤0.01%	3980
2021 Q2	$4.26M	Buy	+1,156,329	New	+$5.22M	﹤0.01%	3943

Other funds holding CANO.WS

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BlackRock's CANO.WS Position: Q4 2023 in Review

BlackRock sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 1,068,828 shares — an estimated $53.4K sold.

BlackRock first reported a position in CANO.WS in Q2 2021 and held it in 10 quarters. The position peaked at $4.78M in Q3 2021. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.

BlackRock reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
BlackRock sold 1,068,828 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $53.4K.
BlackRock first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 10 quarters.
BlackRock's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $4.78M in Q3 2021.
2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.

Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.